18
Oct
Pfizer Inc (NYSE-PFE) receives approval for COVID-19 vaccine for 2023-2024
Pfizer Inc. (NYSE-PFE) announced via press release that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologi...